pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Vaccine · news · pharmadog
← back to Vaccine
News · Vaccine
688
stories
Aug 24, 26
FDA plans to regulate generative AI
stat
Aug 24, 26
Kennedy questions vaccination guidelines following Trump’s order to break up MMR
biospace
Aug 24, 26
STAT+: FDA pauses Regenxbio gene therapy trial again due to safety concerns
stat
Aug 24, 26
Nurse practitioner trainees find themselves stymied by shortage of clinical mentors
stat
Aug 24, 26
STAT+: Medicaid transgender care rule sets precedent that could restrict coverage of other drugs
stat
Aug 24, 26
STAT+: Inside Moderna and Merck’s cancer vaccine triumph
stat
Aug 24, 26
Capricor, Replimune reviews signal FDA’s return to reliability but every application will stand alone
biospace
Aug 22, 26
Third death in China’s expedited trials; Merck and Moderna’s cancer vaccine win; and more
endpoints
Aug 21, 26
Capricor investor calls for change as company awaits decision on Duchenne candidate
biospace
Aug 21, 26
RFK Jr. takes another step toward dismantling vaccine recommendations
endpoints
Aug 21, 26
STAT+: HHS document offers new clues to Kennedy’s vaccine plans
stat
Aug 21, 26
Genentech invests $750M in new factory; Bavarian Nordic delays Lyme trial
endpoints
Aug 21, 26
STAT+: Up and down the ladder: The latest comings and goings
stat
Aug 21, 26
STAT+: Pharmalittle: We’re reading about a big Roche investment in the U.S., estrogen patch shortages, and more
stat
Aug 21, 26
Shareholder pressures Capricor; Lilly dives deeper into vaccines
biopharma dive
Aug 21, 26
Scientists deploy Merck’s Ebola vaccine in DRC
stat
Aug 20, 26
Cancer vaccine win restores Wall Street’s faith in Moderna
biopharma dive
Aug 20, 26
Lilly partners with Amplitude on vaccines; Otsuka scraps psychedelic trial
endpoints
Aug 20, 26
STAT+: FDA approves Ultragenyx gene therapy
stat
Aug 20, 26
Contrasting legal decisions on gender-affirming care
stat
Aug 20, 26
STAT+: Pharmalittle: We’re reading about a Regeneron rare disease drug, an Ultragenyx gene therapy, and more
stat
Aug 20, 26
Merck’s Moderna-partnered vaccine success clears view of post-Keytruda future
biospace
Aug 20, 26
STAT+: One of the most consequential years for cancer treatment, ever
stat
Aug 20, 26
Medigen links up with Charles River in push to take enterovirus vaccine global
fiercebiotech
Aug 20, 26
Lilly pens deal with Gateway Labs resident Amplitude for RNA vaccine platform for infectious disease
fiercebiotech
Aug 20, 26
Merck-Moderna cancer vaccine win spurs stock jump, speculation of Keytruda-like impact
fiercebiotech
Aug 20, 26
Opinion: Capricor’s Duchenne muscular dystrophy drug and the countless tiny decisions that can make or break a study
stat
Aug 20, 26
7 biopharma M&A deals where layoffs followed
biospace
Aug 19, 26
STAT+: How Trump loyalist Heidi Overton became the president’s pick to run the FDA
stat
Aug 19, 26
STAT+: New CDC director tells staff she is prepared to speak ‘truth to power’
stat
← prev
page 13 of 23
next →